Evaluation of Prostate Cancer Margins
Completed
- Conditions
- Prostate Cancer
- Registration Number
- NCT05317143
- Lead Sponsor
- Intuitive Surgical
- Brief Summary
Pathological assessment of prostate tissue
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Male
- Target Recruitment
- 100
Inclusion Criteria
- Diagnosed with prostate cancer
- Subject must be scheduled for robotic-assisted radical prostatectomy at the clinical site.
Exclusion Criteria
- None
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Positive Margin Immediately postoperatively, expected same day as surgery Detection of positive margin
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular markers are associated with prostate cancer margin assessment in NCT05317143?
How does Intuitive Surgical's margin evaluation compare to traditional pathological methods in prostate cancer?
What are the potential adverse events in prostate cancer margin assessment using NCT05317143 methods?
Are there any novel biomarkers identified for patient selection in prostate cancer margin studies?
What are the implications of NCT05317143 findings on current prostate cancer treatment protocols?
Trial Locations
- Locations (1)
St. Antonius Hospital, Prostatazentrum Nordwest
🇩🇪Gronau, Germany
St. Antonius Hospital, Prostatazentrum Nordwest🇩🇪Gronau, Germany